SCHEMBL25015103

SCHEMBL25015103

CCC(CC)N1CCC2(CC1)CNC(=O)O2

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
CHRM2 P08172 1/20 0.46
ADRA2A P08913 1/20 0.46
CYP2D6 P10635 1/20 0.46
TSHR P16473 1/20 0.46
DRD1 P21728 1/20 0.46
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
CDK8 P49336 9/20 0.36
CDK19 Q9BWU1 9/20 0.36
SMO Q99835 1/20 0.36
CCNC P24863 6/20 0.35
CYP11B2 P19099 1/20 0.35
PDCD1LG2 Q9BQ51 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
CHRNA7 P36544 2/20 0.33
HDAC1 Q13547 1/20 0.33
PTPN11 Q06124 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18848901 0.86 LMNA (0.45) LMNACHRM2ADRA2ACYP2D6TSHR
SCHEMBL9963258 0.83 CYP2D6 (0.48) LMNACHRM2ADRA2ACYP2D6TSHR
SCHEMBL21451536 0.81 LMNA (0.41) LMNACHRM2ADRA2ACYP2D6TSHR
SCHEMBL18896609 0.80 LMNA (0.43) LMNACHRM2ADRA2ACYP2D6TSHR
SCHEMBL20007955 0.78 CYP2D6 (0.44) LMNACHRM2ADRA2ACYP2D6TSHR
SCHEMBL18851640 0.78 TSHR (0.56) LMNACHRM2ADRA2ACYP2D6TSHR
SCHEMBL1096010 0.78 LMNA (0.55) LMNACHRM2ADRA2ACYP2D6TSHR
SCHEMBL29341677 0.77 CYP2D6 (0.46) LMNACHRM2ADRA2ACYP2D6TSHR
SCHEMBL21776108 0.76 LMNA (0.42) LMNACHRM2ADRA2ACYP2D6TSHR
SCHEMBL519126 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230038379-A1 MONOCLONAL CELL LINES EXPRESSING AN EXOGENOUS SUBSTANCE AND USES THEREOF SIGILON THERAPEUTICS, INC. 2023-02-09 US disclosed